Planet Briefing

First published · Last updated

Safety Profile of Apalutamide in Prostate Cancer: A Pooled Analysis of Phase III Trials and the Under-Recognized Need for Real-World Thyroid Monitoring

A peer-reviewed article reports a pooled analysis of Phase III trials assessing apalutamide safety in prostate cancer and highlights a need for thyroid monitoring in real-world use. The supplied source fields include only the title, publisher, content type, and publication date.

Categories: public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
3/10
Geographic reach
1/10
Global importance
3/10
Impact magnitude
4/10
Positivity
2/10
Urgency
4/10

Why it matters

Identifies potential safety concerns that could affect monitoring practices for patients taking apalutamide.

Sources

Report an issue